XML 90 R73.htm IDEA: XBRL DOCUMENT v3.8.0.1
SEGMENT INFORMATION (Summary of Reportable Segments) (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2017
USD ($)
Sep. 30, 2017
USD ($)
Jun. 30, 2017
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Sep. 30, 2016
USD ($)
Jun. 30, 2016
USD ($)
Mar. 31, 2016
USD ($)
Dec. 31, 2017
USD ($)
segment
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Financial information regarding the Company's reportable segments                      
Number of reportable segments | segment                 3    
Net Sales $ 625,895 $ 624,326 $ 617,746 $ 601,316 $ 538,868 $ 589,729 $ 619,999 $ 582,338 $ 2,469,283 $ 2,330,934 $ 2,317,149
Interest expense                 (40,597) (35,237) (34,615)
Interest income                 5,470 2,643 5,596
Income before Income Taxes                 294,825 280,497 294,571
Depreciation and amortization                 153,094 154,802 138,893
Capital Expenditures                 156,624 128,986 149,323
Total Assets 3,137,823       2,606,785       3,137,823 2,606,785 2,437,045
Restructuring Initiatives by Segment                      
Total Restructuring Initiatives                 2,208    
Employee severance                      
Restructuring Initiatives by Segment                      
Total Restructuring Initiatives                 2,208    
Business Transformation Plan                      
Financial information regarding the Company's reportable segments                      
Income before interest and taxes                 (2,208)    
Restructuring Initiatives by Segment                      
Total Restructuring Initiatives                 2,208    
Business Transformation Plan | Employee severance                      
Restructuring Initiatives by Segment                      
Total Restructuring Initiatives                 2,208    
Beauty + Home                      
Financial information regarding the Company's reportable segments                      
Net Sales                 1,313,786 1,261,086 1,272,946
Income before interest and taxes                 93,805 100,569 98,707
Depreciation and amortization                 79,422 84,273 75,289
Capital Expenditures                 76,425 75,165 61,156
Total Assets 1,358,283       1,270,858       1,358,283 1,270,858 1,086,482
Restructuring Initiatives by Segment                      
Total Restructuring Initiatives                 529    
Pharma                      
Financial information regarding the Company's reportable segments                      
Net Sales                 805,880 741,473 712,220
Income before interest and taxes                 234,790 219,039 210,509
Depreciation and amortization                 41,143 39,776 36,008
Capital Expenditures                 33,005 58,970 48,133
Total Assets 881,443       831,569       881,443 831,569 591,500
Food + Beverage                      
Financial information regarding the Company's reportable segments                      
Net Sales                 349,617 328,375 331,983
Income before interest and taxes                 38,183 37,697 42,731
Depreciation and amortization                 24,720 23,891 21,347
Capital Expenditures                 38,730 21,533 25,337
Total Assets 296,271       259,282       296,271 259,282 250,369
Restructuring Initiatives by Segment                      
Total Restructuring Initiatives                 1,679    
Corporate & Other                      
Financial information regarding the Company's reportable segments                      
Income before interest and taxes                 (34,618) (44,214) (28,357)
Depreciation and amortization                 7,809 6,862 6,249
Capital Expenditures                 18,924 17,490 23,149
Transfer of Corporate Technology Expenditures                 (10,460) (44,172) (8,452)
Total Assets $ 601,826       $ 245,076       601,826 245,076 508,694
Operating segment                      
Financial information regarding the Company's reportable segments                      
Net Sales                 2,491,444 2,349,855 2,339,130
Operating segment | Beauty + Home                      
Financial information regarding the Company's reportable segments                      
Net Sales                 1,333,048 1,278,151 1,291,545
Operating segment | Pharma                      
Financial information regarding the Company's reportable segments                      
Net Sales                 805,913 741,473 712,220
Operating segment | Food + Beverage                      
Financial information regarding the Company's reportable segments                      
Net Sales                 352,483 330,231 335,365
Intersegment                      
Financial information regarding the Company's reportable segments                      
Net Sales                 (22,161) (18,921) (21,981)
Intersegment | Beauty + Home                      
Financial information regarding the Company's reportable segments                      
Net Sales                 (19,262) (17,065) (18,599)
Intersegment | Pharma                      
Financial information regarding the Company's reportable segments                      
Net Sales                 (33)    
Intersegment | Food + Beverage                      
Financial information regarding the Company's reportable segments                      
Net Sales                 $ (2,866) $ (1,856) $ (3,382)